| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 05/01/2012 | US8168815 Fused aromatic PTP-1B inhibitors |
| 05/01/2012 | US8168792 Heterocyclic antiviral compounds |
| 05/01/2012 | CA2556669C Hepatitis c inhibitor peptide analogs |
| 04/26/2012 | WO2012053573A1 Method for producing 2,2,4-trimethyl-1,2-dihydroquinoline polymer-containing compositions |
| 04/26/2012 | WO2012053572A1 Method for producing 2,2,4-trimethyl-1,2-dihydroquinoline polymer-containing compositions |
| 04/26/2012 | WO2012052451A1 Metabotropic glutamate receptor modulators |
| 04/26/2012 | WO2012052372A1 Tetrahydroquinoline derivatives used as ampk activators |
| 04/26/2012 | WO2012015255A3 Novel montelukast 4-halobenzylamine salt and method for preparing montelukast sodium salt by using the same |
| 04/26/2012 | US20120101127 Novel tetrahydroquinoline derivatives |
| 04/26/2012 | US20120101126 Crystalline forms of pitavastatin calcium |
| 04/26/2012 | US20120101116 Substituted heterocyclic compounds as kinases inhibitors and methods of use thereof |
| 04/26/2012 | US20120101082 Vasopressin v1a antagonists |
| 04/26/2012 | US20120101075 Derivatives of 4-(2-Amino-1-Hydroxyethyl) Phenol as Agonists of the Beta2 Adrenergic Receptor |
| 04/26/2012 | CA2814594A1 Tetrahydroquinoline derivatives used as ampk activators |
| 04/25/2012 | EP2443092A1 Bicyclic and tricyclic compounds as kat ii inhibitors |
| 04/25/2012 | EP1885684B9 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta-2 adrenergic receptor |
| 04/25/2012 | EP1828137B1 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments |
| 04/25/2012 | CN102427853A Protease Inhibitors |
| 04/25/2012 | CN102424673A Montelukast sodium intermediate and method for synthesizing montelukast sodium thereof |
| 04/25/2012 | CN102424669A 一种6-羟基-2(1h)-喹啉酮化合物的制备方法 One kind of 6-hydroxy -2 (1h) - quinolinone compound prepared in |
| 04/25/2012 | CN101849953B 炎症性细胞因子产生游离抑制剂 Inflammatory cytokine production inhibitor free |
| 04/24/2012 | US8163936 Treatment of CRTH2-mediated diseases and conditions |
| 04/24/2012 | US8163931 Treatment of CRTH2-mediated diseases and conditions |
| 04/24/2012 | US8163924 Process for preparing a leukotriene antagonist and an intermediate thereof |
| 04/24/2012 | US8163923 Benzyl 1-((6-methoxy-4-(5-(methylcarbamoyl)naphthalen-2-yloxy)quinolin-7-yloxy)methyl)cyclo-propylcarbamate; cancers associated with protein tyrosine kinases |
| 04/24/2012 | US8163922 Process for the preparation of 8-hydroxy-5-[(1R)-1-hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone monohydrochloride |
| 04/24/2012 | US8163772 Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxypheny1]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 04/24/2012 | US8163769 1,8-naphthyridine derivatives |
| 04/24/2012 | US8163753 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria |
| 04/24/2012 | US8163751 Acylated indanyl amines and their use as pharmaceuticals |
| 04/24/2012 | CA2700314C Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists |
| 04/19/2012 | WO2012050500A1 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators. |
| 04/19/2012 | WO2012050371A1 Novel compounds for organic electronic material and organic electroluminescent device using the same |
| 04/19/2012 | WO2012050347A1 Novel compounds for organic electronic material and organic electroluminescent device using the same |
| 04/19/2012 | WO2012050041A1 Aryloxyurea compound and pest control agent |
| 04/19/2012 | WO2012048894A1 Hybrid compounds of 4- and 8-aminoquinolines for the prophylactic and therapeutic treatment of malaria and other parasitic diseases |
| 04/19/2012 | WO2011155803A3 Novel compound having hearing protection effects |
| 04/19/2012 | US20120095045 Injectable anticancer composition for local administration containing hydroxychloroquine |
| 04/19/2012 | US20120095042 Organic Compounds Having Cooling Properties |
| 04/19/2012 | US20120094977 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 04/19/2012 | US20120094958 Quinolines as inhibitors of farnesyl pyrophosphate synthase |
| 04/19/2012 | US20120094833 Herbicidal quinoline and 1,8 -naphthyridine compounds |
| 04/19/2012 | CA2813908A1 Aryloxyurea compound and pest control agent |
| 04/19/2012 | CA2813711A1 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators. |
| 04/18/2012 | EP2440546A2 Compounds useful for treating premature aging and in particular progeria |
| 04/18/2012 | EP2440545A2 Compounds useful for treating cancer |
| 04/18/2012 | EP1192139B1 Preparation of quinoline-substituted carbonate and carbamate derivatives |
| 04/18/2012 | CN102417508A 作为新陈代谢调节剂的稠合芳基和杂芳基衍生物以及预防和治疗与其相关的病症 A fused aryl and heteroaryl metabolic modulators aryl derivatives and the prevention and treatment of disorders associated therewith |
| 04/18/2012 | CN102417479A Stat3小分子选择性抑制剂及其制备方法和应用 Selective small molecule inhibitors of Stat3 and its preparation method and application |
| 04/18/2012 | CN101870674B 改进的瑞巴派特中间体的制备方法 Improved preparation of intermediates Rebamipide |
| 04/18/2012 | CN101579343B Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 04/18/2012 | CN101362719B 喹啉类衍生物以及包含其的组合物 Quinoline derivatives and compositions containing them |
| 04/17/2012 | US8158825 Modified malonate derivatives |
| 04/17/2012 | US8158820 Compounds |
| 04/17/2012 | US8158798 Coupling process for preparing quinolone intermediates |
| 04/17/2012 | US8158797 Oxazolidinone-quinolone hybrid antibiotics |
| 04/17/2012 | US8158650 Substituted phenylmethyl bicyclocarboxyamide compounds |
| 04/17/2012 | US8158643 Substituted diaza-spiro-pyridinone derivatives for use in MCH-1 mediated diseases |
| 04/17/2012 | US8158640 Tetrahydroquinoline derivatives and a process for preparing the same |
| 04/17/2012 | CA2427844C Naphthalene derivatives |
| 04/12/2012 | WO2012046771A1 Cycloalkane compound |
| 04/12/2012 | US20120088770 Alpha helix mimetics and methods relating thereto |
| 04/12/2012 | US20120088754 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 04/12/2012 | US20120088746 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 04/11/2012 | EP2439203A1 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 04/11/2012 | EP2439195A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof |
| 04/11/2012 | EP2438046A2 O-glcnac transferase inhibitors and uses thereof |
| 04/11/2012 | EP1902030B1 Substituted quinolones ii |
| 04/11/2012 | EP1650191B1 Therapeutic agent for chronic obstructive pulmonary disease and method of treatment for chronic obstructive pulmonary disease with the same |
| 04/11/2012 | EP1326840B1 Substituted heterocyclic compounds for treating multidrug resistance |
| 04/11/2012 | CN102414180A 作为沉默调节蛋白调节剂的8-取代的喹啉及相关的类似物 As a sirtuin modulators 8-substituted quinoline and related analogs |
| 04/11/2012 | CN102408411A Hydroximic acid compound containing quinolyl and preparation method thereof, and drug composition containing the compound and use thereof |
| 04/11/2012 | CN102406634A Hiv-1整合酶抑制剂 Hiv-1 integrase inhibitors |
| 04/10/2012 | US8153843 Antibacterial agents |
| 04/10/2012 | US8153803 Compositions and methods for modulating sirtuin activity |
| 04/10/2012 | US8153802 Dyes linked to target molecules, oligonucleotides or polynucleotides comprising dye molecules, composite dyes and other compositions useful for detecting or quantifying desirable target molecules |
| 04/10/2012 | US8153801 Process and intermediates for preparing integrase inhibitors |
| 04/10/2012 | US8153800 Macrocyclic inhibitors of hepatitis C virus |
| 04/10/2012 | CA2612976C Amide derivative and insecticide containing the same |
| 04/05/2012 | WO2012042915A1 Sulfamoyl benzoic acid heterobicyclic derivatives as trpm8 antagonists |
| 04/05/2012 | WO2012041873A1 N-heteroaryl compounds |
| 04/05/2012 | WO2012041493A1 Aminoquinolinium salts, methods of their production and their use as active agents for biotechnological and medical applications against binary toxins |
| 04/05/2012 | WO2011156728A3 Zinc sensors for cellular imaging |
| 04/05/2012 | US20120083478 Crystalline oxalate salts of a diamide compound |
| 04/05/2012 | CA2811369A1 N-heteroaryl compounds |
| 04/04/2012 | EP1911743B1 Cyclic amine compound |
| 04/04/2012 | EP1338336B1 Use of catalysts comprising n-substituted cyclic imides for preparing organic compounds |
| 04/04/2012 | CN102399185A 一种2-甲基喹啉的精制方法 One kind of method for purifying 2- methyl-quinoline |
| 04/04/2012 | CN101921238B 取代苯并氮杂环类衍生物的制备及其药理用途 Benzazepine ring-substituted derivatives of preparation and pharmacological uses |
| 04/04/2012 | CN101501000B 孟鲁司特和其胺盐的纯化方法 Purification of montelukast and its amine salt |
| 04/03/2012 | US8148540 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
| 04/03/2012 | US8148532 Benzyl 1-((4-(1H-indol-5-ylamino)-6-methoxyquinolin-7-yloxy)methyl)cyclopropylcarbamate; cancers associated with protein tyrosine kinases |
| 04/03/2012 | US8148531 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
| 04/03/2012 | US8148424 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 04/03/2012 | US8147872 Pharmaceutical compositions of drugs and neutralized acidic polymers |
| 04/03/2012 | CA2554187C 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinolines compound |
| 04/03/2012 | CA2505427C Bicyclic-substituted amines as histamine-3 receptor ligands |
| 04/03/2012 | CA2439663C Process for producing quinoline-3-carboxylic acid compound |
| 03/29/2012 | US20120077985 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 03/29/2012 | US20120077838 Beta-2-Adrenoreceptor Agonists |